Loading…
The effects of poloxamer and sodium alginate mixture
Restricted shoulder mobility is a major upper extremity dysfunction associated with lower quality of life and disability after breast cancer surgery. We hypothesized that a poloxamer and sodium alginate mixture (Guardix-SG®) applied after axillary lymph node dissection (ALND) would significantly imp...
Saved in:
Published in: | PloS one 2020-09, Vol.15 (9), p.e0238284 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 9 |
container_start_page | e0238284 |
container_title | PloS one |
container_volume | 15 |
creator | Lee, Sae Byul Gwark, Sung-chan Kang, Cheol Min Sohn, Guiyun Kim, Jisun Chung, Il Yong Lee, Jong Won Kim, Hee Jeong Ko, Beom Seok Ahn, Sei-Hyun Kim, Won Do, Junghwa Jeon, Jae Yong Kim, Jinsung Um, Eunhae Yoon, Tae in Jung, Sung-ui Han, Minkyu Son, Byung Ho |
description | Restricted shoulder mobility is a major upper extremity dysfunction associated with lower quality of life and disability after breast cancer surgery. We hypothesized that a poloxamer and sodium alginate mixture (Guardix-SG®) applied after axillary lymph node dissection (ALND) would significantly improve shoulder range of motion (ROM) in patients with breast cancer. We conducted a double-blind, randomized, prospective study to evaluate the clinical efficacy and safety of Guardix-SG® for the prevention of upper extremity dysfunction after ALND. The primary outcome measure was shoulder ROM at baseline (T0) and 3 (T1), 6 (T2), and 12 months (T3) after surgery. Secondary outcome measures were the Disabilities of the Arm, Shoulder, and Hand score(DASH), pain associated with movement, which was assessed using a numeric rating scale, and lymphedema assessed using body composition analyzer. A total of 83 women with breast cancer were randomly assigned to either the Guardix-SG® group or the control group. In the Guardix-SG® group (n = 37), Guardix-SG® was applied to the axillary region after ALND. In the control group (n = 46), ALND was performed without using Guardix-SG®. The results of this study have shown that Guardix-SG® help improve shoulder ROM without causing adverse effects in patients who underwent breast cancer surgery. However, there was no statistically significant difference from the control group. A further large-scale study is needed to obtain a more conclusive conclusion. |
doi_str_mv | 10.1371/journal.pone.0238284 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_incontextgauss_ISR_A636294746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A636294746</galeid><sourcerecordid>A636294746</sourcerecordid><originalsourceid>FETCH-LOGICAL-g996-8cc69dcd2ffff8c18f9c087bb49cbf7bf06eb34327e8cd1d7d16bee416b88a6c3</originalsourceid><addsrcrecordid>eNqFzEtLAzEUBeAgCtbqP3CRleBial5mkmUpPgqFgha3JZPczEzJJKXJQH--BV3UlXdxzll8XITuKZlRXtOnXRoP0YTZPkWYEcYVU-ICTajmrJKM8MuzfY1uct4R8syVlBMkNh1g8B5syTh5vE8hHc0AB2yiwzm5fhywCW0fTQE89McyHuAWXXkTMtz99hRtXl82i_dqtX5bLuarqtVaVspaqZ11zJ9OWaq8tkTVTSO0bXzdeCKh4YKzGpR11NWOygZAnFIpIy2foseft60JsO2jTbHAsbRmzHm7_PzYziWXTItayH_s-uuvfTizHZhQupzCWPoU8zn8Bve8Z7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The effects of poloxamer and sodium alginate mixture</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Lee, Sae Byul ; Gwark, Sung-chan ; Kang, Cheol Min ; Sohn, Guiyun ; Kim, Jisun ; Chung, Il Yong ; Lee, Jong Won ; Kim, Hee Jeong ; Ko, Beom Seok ; Ahn, Sei-Hyun ; Kim, Won ; Do, Junghwa ; Jeon, Jae Yong ; Kim, Jinsung ; Um, Eunhae ; Yoon, Tae in ; Jung, Sung-ui ; Han, Minkyu ; Son, Byung Ho</creator><creatorcontrib>Lee, Sae Byul ; Gwark, Sung-chan ; Kang, Cheol Min ; Sohn, Guiyun ; Kim, Jisun ; Chung, Il Yong ; Lee, Jong Won ; Kim, Hee Jeong ; Ko, Beom Seok ; Ahn, Sei-Hyun ; Kim, Won ; Do, Junghwa ; Jeon, Jae Yong ; Kim, Jinsung ; Um, Eunhae ; Yoon, Tae in ; Jung, Sung-ui ; Han, Minkyu ; Son, Byung Ho</creatorcontrib><description>Restricted shoulder mobility is a major upper extremity dysfunction associated with lower quality of life and disability after breast cancer surgery. We hypothesized that a poloxamer and sodium alginate mixture (Guardix-SG®) applied after axillary lymph node dissection (ALND) would significantly improve shoulder range of motion (ROM) in patients with breast cancer. We conducted a double-blind, randomized, prospective study to evaluate the clinical efficacy and safety of Guardix-SG® for the prevention of upper extremity dysfunction after ALND. The primary outcome measure was shoulder ROM at baseline (T0) and 3 (T1), 6 (T2), and 12 months (T3) after surgery. Secondary outcome measures were the Disabilities of the Arm, Shoulder, and Hand score(DASH), pain associated with movement, which was assessed using a numeric rating scale, and lymphedema assessed using body composition analyzer. A total of 83 women with breast cancer were randomly assigned to either the Guardix-SG® group or the control group. In the Guardix-SG® group (n = 37), Guardix-SG® was applied to the axillary region after ALND. In the control group (n = 46), ALND was performed without using Guardix-SG®. The results of this study have shown that Guardix-SG® help improve shoulder ROM without causing adverse effects in patients who underwent breast cancer surgery. However, there was no statistically significant difference from the control group. A further large-scale study is needed to obtain a more conclusive conclusion.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0238284</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Alginate chemicals ; Complications and side effects ; Drug therapy ; Health aspects ; Lymph node excision ; Methods ; Patient outcomes ; Poloxamers ; Postoperative care ; Postoperative complications</subject><ispartof>PloS one, 2020-09, Vol.15 (9), p.e0238284</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lee, Sae Byul</creatorcontrib><creatorcontrib>Gwark, Sung-chan</creatorcontrib><creatorcontrib>Kang, Cheol Min</creatorcontrib><creatorcontrib>Sohn, Guiyun</creatorcontrib><creatorcontrib>Kim, Jisun</creatorcontrib><creatorcontrib>Chung, Il Yong</creatorcontrib><creatorcontrib>Lee, Jong Won</creatorcontrib><creatorcontrib>Kim, Hee Jeong</creatorcontrib><creatorcontrib>Ko, Beom Seok</creatorcontrib><creatorcontrib>Ahn, Sei-Hyun</creatorcontrib><creatorcontrib>Kim, Won</creatorcontrib><creatorcontrib>Do, Junghwa</creatorcontrib><creatorcontrib>Jeon, Jae Yong</creatorcontrib><creatorcontrib>Kim, Jinsung</creatorcontrib><creatorcontrib>Um, Eunhae</creatorcontrib><creatorcontrib>Yoon, Tae in</creatorcontrib><creatorcontrib>Jung, Sung-ui</creatorcontrib><creatorcontrib>Han, Minkyu</creatorcontrib><creatorcontrib>Son, Byung Ho</creatorcontrib><title>The effects of poloxamer and sodium alginate mixture</title><title>PloS one</title><description>Restricted shoulder mobility is a major upper extremity dysfunction associated with lower quality of life and disability after breast cancer surgery. We hypothesized that a poloxamer and sodium alginate mixture (Guardix-SG®) applied after axillary lymph node dissection (ALND) would significantly improve shoulder range of motion (ROM) in patients with breast cancer. We conducted a double-blind, randomized, prospective study to evaluate the clinical efficacy and safety of Guardix-SG® for the prevention of upper extremity dysfunction after ALND. The primary outcome measure was shoulder ROM at baseline (T0) and 3 (T1), 6 (T2), and 12 months (T3) after surgery. Secondary outcome measures were the Disabilities of the Arm, Shoulder, and Hand score(DASH), pain associated with movement, which was assessed using a numeric rating scale, and lymphedema assessed using body composition analyzer. A total of 83 women with breast cancer were randomly assigned to either the Guardix-SG® group or the control group. In the Guardix-SG® group (n = 37), Guardix-SG® was applied to the axillary region after ALND. In the control group (n = 46), ALND was performed without using Guardix-SG®. The results of this study have shown that Guardix-SG® help improve shoulder ROM without causing adverse effects in patients who underwent breast cancer surgery. However, there was no statistically significant difference from the control group. A further large-scale study is needed to obtain a more conclusive conclusion.</description><subject>Alginate chemicals</subject><subject>Complications and side effects</subject><subject>Drug therapy</subject><subject>Health aspects</subject><subject>Lymph node excision</subject><subject>Methods</subject><subject>Patient outcomes</subject><subject>Poloxamers</subject><subject>Postoperative care</subject><subject>Postoperative complications</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFzEtLAzEUBeAgCtbqP3CRleBial5mkmUpPgqFgha3JZPczEzJJKXJQH--BV3UlXdxzll8XITuKZlRXtOnXRoP0YTZPkWYEcYVU-ICTajmrJKM8MuzfY1uct4R8syVlBMkNh1g8B5syTh5vE8hHc0AB2yiwzm5fhywCW0fTQE89McyHuAWXXkTMtz99hRtXl82i_dqtX5bLuarqtVaVspaqZ11zJ9OWaq8tkTVTSO0bXzdeCKh4YKzGpR11NWOygZAnFIpIy2foseft60JsO2jTbHAsbRmzHm7_PzYziWXTItayH_s-uuvfTizHZhQupzCWPoU8zn8Bve8Z7A</recordid><startdate>20200923</startdate><enddate>20200923</enddate><creator>Lee, Sae Byul</creator><creator>Gwark, Sung-chan</creator><creator>Kang, Cheol Min</creator><creator>Sohn, Guiyun</creator><creator>Kim, Jisun</creator><creator>Chung, Il Yong</creator><creator>Lee, Jong Won</creator><creator>Kim, Hee Jeong</creator><creator>Ko, Beom Seok</creator><creator>Ahn, Sei-Hyun</creator><creator>Kim, Won</creator><creator>Do, Junghwa</creator><creator>Jeon, Jae Yong</creator><creator>Kim, Jinsung</creator><creator>Um, Eunhae</creator><creator>Yoon, Tae in</creator><creator>Jung, Sung-ui</creator><creator>Han, Minkyu</creator><creator>Son, Byung Ho</creator><general>Public Library of Science</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20200923</creationdate><title>The effects of poloxamer and sodium alginate mixture</title><author>Lee, Sae Byul ; Gwark, Sung-chan ; Kang, Cheol Min ; Sohn, Guiyun ; Kim, Jisun ; Chung, Il Yong ; Lee, Jong Won ; Kim, Hee Jeong ; Ko, Beom Seok ; Ahn, Sei-Hyun ; Kim, Won ; Do, Junghwa ; Jeon, Jae Yong ; Kim, Jinsung ; Um, Eunhae ; Yoon, Tae in ; Jung, Sung-ui ; Han, Minkyu ; Son, Byung Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g996-8cc69dcd2ffff8c18f9c087bb49cbf7bf06eb34327e8cd1d7d16bee416b88a6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alginate chemicals</topic><topic>Complications and side effects</topic><topic>Drug therapy</topic><topic>Health aspects</topic><topic>Lymph node excision</topic><topic>Methods</topic><topic>Patient outcomes</topic><topic>Poloxamers</topic><topic>Postoperative care</topic><topic>Postoperative complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Sae Byul</creatorcontrib><creatorcontrib>Gwark, Sung-chan</creatorcontrib><creatorcontrib>Kang, Cheol Min</creatorcontrib><creatorcontrib>Sohn, Guiyun</creatorcontrib><creatorcontrib>Kim, Jisun</creatorcontrib><creatorcontrib>Chung, Il Yong</creatorcontrib><creatorcontrib>Lee, Jong Won</creatorcontrib><creatorcontrib>Kim, Hee Jeong</creatorcontrib><creatorcontrib>Ko, Beom Seok</creatorcontrib><creatorcontrib>Ahn, Sei-Hyun</creatorcontrib><creatorcontrib>Kim, Won</creatorcontrib><creatorcontrib>Do, Junghwa</creatorcontrib><creatorcontrib>Jeon, Jae Yong</creatorcontrib><creatorcontrib>Kim, Jinsung</creatorcontrib><creatorcontrib>Um, Eunhae</creatorcontrib><creatorcontrib>Yoon, Tae in</creatorcontrib><creatorcontrib>Jung, Sung-ui</creatorcontrib><creatorcontrib>Han, Minkyu</creatorcontrib><creatorcontrib>Son, Byung Ho</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Sae Byul</au><au>Gwark, Sung-chan</au><au>Kang, Cheol Min</au><au>Sohn, Guiyun</au><au>Kim, Jisun</au><au>Chung, Il Yong</au><au>Lee, Jong Won</au><au>Kim, Hee Jeong</au><au>Ko, Beom Seok</au><au>Ahn, Sei-Hyun</au><au>Kim, Won</au><au>Do, Junghwa</au><au>Jeon, Jae Yong</au><au>Kim, Jinsung</au><au>Um, Eunhae</au><au>Yoon, Tae in</au><au>Jung, Sung-ui</au><au>Han, Minkyu</au><au>Son, Byung Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of poloxamer and sodium alginate mixture</atitle><jtitle>PloS one</jtitle><date>2020-09-23</date><risdate>2020</risdate><volume>15</volume><issue>9</issue><spage>e0238284</spage><pages>e0238284-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Restricted shoulder mobility is a major upper extremity dysfunction associated with lower quality of life and disability after breast cancer surgery. We hypothesized that a poloxamer and sodium alginate mixture (Guardix-SG®) applied after axillary lymph node dissection (ALND) would significantly improve shoulder range of motion (ROM) in patients with breast cancer. We conducted a double-blind, randomized, prospective study to evaluate the clinical efficacy and safety of Guardix-SG® for the prevention of upper extremity dysfunction after ALND. The primary outcome measure was shoulder ROM at baseline (T0) and 3 (T1), 6 (T2), and 12 months (T3) after surgery. Secondary outcome measures were the Disabilities of the Arm, Shoulder, and Hand score(DASH), pain associated with movement, which was assessed using a numeric rating scale, and lymphedema assessed using body composition analyzer. A total of 83 women with breast cancer were randomly assigned to either the Guardix-SG® group or the control group. In the Guardix-SG® group (n = 37), Guardix-SG® was applied to the axillary region after ALND. In the control group (n = 46), ALND was performed without using Guardix-SG®. The results of this study have shown that Guardix-SG® help improve shoulder ROM without causing adverse effects in patients who underwent breast cancer surgery. However, there was no statistically significant difference from the control group. A further large-scale study is needed to obtain a more conclusive conclusion.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0238284</doi><tpages>e0238284</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2020-09, Vol.15 (9), p.e0238284 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_gale_incontextgauss_ISR_A636294746 |
source | PubMed Central Free; Publicly Available Content Database |
subjects | Alginate chemicals Complications and side effects Drug therapy Health aspects Lymph node excision Methods Patient outcomes Poloxamers Postoperative care Postoperative complications |
title | The effects of poloxamer and sodium alginate mixture |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A32%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20poloxamer%20and%20sodium%20alginate%20mixture&rft.jtitle=PloS%20one&rft.au=Lee,%20Sae%20Byul&rft.date=2020-09-23&rft.volume=15&rft.issue=9&rft.spage=e0238284&rft.pages=e0238284-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0238284&rft_dat=%3Cgale%3EA636294746%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g996-8cc69dcd2ffff8c18f9c087bb49cbf7bf06eb34327e8cd1d7d16bee416b88a6c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A636294746&rfr_iscdi=true |